s6y
Company name or ticker
Search
Telomir Pharmaceuticals, Inc.
3
MIRA PHARMACEUTICALS, INC.: Initial statement of beneficial ownership of securities
Filed
Friday, October 3, 2025
Period
Sep 29, 2025
Accession number
0001493152-25-016956
Documents
ownership.xml
3
On sec.gov
Filing index
All files
Complete submission text
SGML header